Genotyping and genomic profiling of non-small-cell lung cancer: implications for current and future therapies.

Abstract excerpt

Substantial advances have been made in understanding critical molecular and cellular mechanisms driving tumor initiation, maintenance, and progression in non-small-cell lung cancer (NSCLC). Over the last decade, these findings have led to the discovery of a variety of novel drug targets and the development of new treatment strategies. Already, the standard of care for patients with advanced-stage NSCLC is...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Algorithms
• Share to Biomarkers, Tumor